BML Investment Partners L.P. 13D and 13G filings for Gemini Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-04-13 4:11 pm Purchase |
2022-04-11 | 13G | Gemini Therapeutics, Inc. GMTX |
BML Investment Partners L.P. | 527,000 12.200% |
294,030 (+126.21%) |
Filing |
| 2022-03-10 2:01 pm Unchanged |
2022-03-04 | 13G | Gemini Therapeutics, Inc. GMTX |
BML Investment Partners L.P. | 232,970 5.400% |
0 (Unchanged) |
Filing |
| 2022-03-10 1:16 pm Purchase |
2022-03-04 | 13G | Gemini Therapeutics, Inc. GMTX |
BML Investment Partners L.P. | 232,970 5.400% |
232,970 (New Position) |
Filing |